Left Atrial Appendage Closure Market Research Report covers the present scenario and the growth prospects of the Left Atrial Appendage Closure Industry for 2017-2021. Left Atrial Appendage Closure Market, has been prepared based on an in-depth market analysis with inputs from industry experts.
The report covers the market landscape and its growth prospects over the coming years and discussion of the key vendors effective in this market. To calculate the market size, the report considers the revenue generated from the sales of Left Atrial Appendage Closure globally.
For further information on this report, please visit- http://www.marketreportsworld.com/10294071
The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors. The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry.
Following Companies Are Key Players of the Left Atrial Appendage Closure Market:
• Boston Scientific
• Coherex Medical
• St. Jude Medical
Other Prominent Vendors of Left Atrial Appendage Closure Market Are:
• Lifetech Scientific
“The increasing clinical trials of research organizations and vendors will expand the application of LAA closure devices by driving the revenue in the market. For new product approval and fulfilled regulatory procedures, it is necessary to carry out clinical trials. Various universities and vendors sponsor this clinical trial. Vendors focus on such trials because positive or negative clinical results of long-term follow-up from trials have an impact on the market. For instance, Novosibirsk Research Institute Of Blood Circulation Pathology and Boston Scientific are conducting a phase II clinical trial to evaluate the safety concern issues of implantation of LAA closure. The process is compared to the standard antiplatelet therapy for the prevention of thromboembolic events and stent thrombosis in individuals with atrial fibrillation who underwent percutaneous coronary intervention.”
Ask Sample PDF of Left Atrial Appendage Closure Market Report @http://www.marketreportsworld.com/enquiry/request-sample/10294071
According to the report, the growing incidences of atrial fibrillation increase the demand for LAA closure devices. Atrial fibrillation is the most common type of heart arrhythmia in which the heart beats at a rapid and irregular pace. The irregular heart rhythm fluctuates the blood flow from the heart, causing blood to stagnate in the LAA, form clots, and increase the risk of stroke. There are some risk factors such as diabetes, cigarette smoking, obesity, and cardiovascular diseases that lead to atrial fibrillation. LAA closure devices play a pivotal role in managing stroke risk in atrial fibrillation patients. Among the many cardiovascular diseases, atrial fibrillation is a common risk factor, which leads to stroke in some individuals. The LAA closure device is used to close the appendage that occurs in the left atria and reduces the risk of stroke. LAA closure devices are minimally invasive, which offers a novel approach for atrial fibrillation treatment.
Report also presents Geographical Segmentation analysis of Left Atrial Appendage Closure Market of Americas, APAC, EMEA region.
For Any Query, Contact Our Expert @ http://www.marketreportsworld.com/enquiry/pre-order-enquiry/10294071
Further, the report states that rrugs are an alternative treatment option for LAA closure devices. Though these devices are more effective and safer than drugs, they are less preferred. LAA closure device costs are required only once, while costs for warfarin and dabigatran continue to accrue year over year. This factor compels the preference for warfarin and dabigatran by consumers. The drugs used to treat diseases are less invasive in nature. Also, warfarin and dabigatran are used for treatment instead of LAA closure devices, as only a few people are aware of LAA closure devices, and its implants have complicated procedures. Also, the introduction of improved drug delivery techniques and enhanced drug pipelines for the treatment of atrial fibrillation diseases restrict the market growth. Thus, the increased acceptance of warfarin and dabigatran will hamper the growth of the market.
Key questions answered in Left Atrial Appendage Closure market report:
No of Pages: 115
Price of Report: $ 3500 (Single User License)
Purchase Report @ http://www.marketreportsworld.com/purchase/10294071
About Market Reports World:
Market Reports World is the credible source for gaining the market research reports that will exponentially accelerate your business. We are among the leading report resellers in the business world committed towards optimizing your business. The reports we provide are based on a research that covers a magnitude of factors such as technological evolution, economic shifts and a detailed study of market segments.
Mr. Ameya Pingaley
Market Reports World
+1 408 520 9750
Email – firstname.lastname@example.org